| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1180459
[patent_doc_number] => 06737259
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-18
[patent_title] => 'Modified arginine deiminase'
[patent_app_type] => B1
[patent_app_number] => 09/723546
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 17
[patent_no_of_words] => 13252
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/737/06737259.pdf
[firstpage_image] =>[orig_patent_app_number] => 09723546
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/723546 | Modified arginine deiminase | Nov 27, 2000 | Issued |
Array
(
[id] => 671803
[patent_doc_number] => 07090843
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-08-15
[patent_title] => 'Recombinant anti-CD30 antibodies and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 09/724406
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 24501
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/090/07090843.pdf
[firstpage_image] =>[orig_patent_app_number] => 09724406
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/724406 | Recombinant anti-CD30 antibodies and uses thereof | Nov 27, 2000 | Issued |
Array
(
[id] => 1148144
[patent_doc_number] => 06774217
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-10
[patent_title] => 'FHIT proteins and nucleic acids and methods based thereon'
[patent_app_type] => B1
[patent_app_number] => 09/717054
[patent_app_country] => US
[patent_app_date] => 2000-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 13
[patent_no_of_words] => 45007
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/774/06774217.pdf
[firstpage_image] =>[orig_patent_app_number] => 09717054
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/717054 | FHIT proteins and nucleic acids and methods based thereon | Nov 20, 2000 | Issued |
| 09/717883 | Novel method of diagnosing, monitoring, staging, imaging and treating cancer | Nov 20, 2000 | Abandoned |
| 09/713299 | The use of mosquito salivary tachykinins to remediate unregulated cellular proliferation | Nov 15, 2000 | Abandoned |
Array
(
[id] => 803414
[patent_doc_number] => 07423118
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-09-09
[patent_title] => 'IAPS associated cell cycle proteins, compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 09/715725
[patent_app_country] => US
[patent_app_date] => 2000-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 26481
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/423/07423118.pdf
[firstpage_image] =>[orig_patent_app_number] => 09715725
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/715725 | IAPS associated cell cycle proteins, compositions and methods of use | Nov 15, 2000 | Issued |
| 09/711216 | 21910, a novel human membrane-associated guanylate kinase and uses thereof | Nov 8, 2000 | Abandoned |
| 09/708222 | 46867 transferase family members and uses therefor | Nov 6, 2000 | Abandoned |
Array
(
[id] => 1229123
[patent_doc_number] => 06696546
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-24
[patent_title] => 'Peptide that kills growing but not stationary cells'
[patent_app_type] => B1
[patent_app_number] => 09/707263
[patent_app_country] => US
[patent_app_date] => 2000-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 24
[patent_no_of_words] => 9957
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/696/06696546.pdf
[firstpage_image] =>[orig_patent_app_number] => 09707263
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/707263 | Peptide that kills growing but not stationary cells | Nov 5, 2000 | Issued |
| 09/380983 | Radiolabelled somatostatin receptor ligands for diagnosis and therapy | Oct 29, 2000 | Abandoned |
| 09/702257 | Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators | Oct 29, 2000 | Abandoned |
Array
(
[id] => 1091790
[patent_doc_number] => 06824780
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-30
[patent_title] => 'Anti-tumor antibody compositions and methods of use'
[patent_app_type] => B1
[patent_app_number] => 09/698705
[patent_app_country] => US
[patent_app_date] => 2000-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 33
[patent_no_of_words] => 43390
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/824/06824780.pdf
[firstpage_image] =>[orig_patent_app_number] => 09698705
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/698705 | Anti-tumor antibody compositions and methods of use | Oct 26, 2000 | Issued |
| 09/694538 | Cadherin peptides for drug delivery and inhibittion of tumor metastasis/invasion | Oct 22, 2000 | Abandoned |
Array
(
[id] => 1323363
[patent_doc_number] => 06602674
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-05
[patent_title] => 'Uses of antileukoprotease in carcinoma'
[patent_app_type] => B1
[patent_app_number] => 09/692820
[patent_app_country] => US
[patent_app_date] => 2000-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 6669
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/602/06602674.pdf
[firstpage_image] =>[orig_patent_app_number] => 09692820
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/692820 | Uses of antileukoprotease in carcinoma | Oct 17, 2000 | Issued |
| 09/623035 | Tumor associated antigen 791tgp72 | Oct 11, 2000 | Abandoned |
| 09/600981 | Inhibition of dna modulation caused by mutated p53 | Oct 3, 2000 | Abandoned |
| 09/679460 | Endozepine-like polypeptides and polynucleotides encoding same | Oct 3, 2000 | Abandoned |
Array
(
[id] => 865139
[patent_doc_number] => 07368545
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-05-06
[patent_title] => 'PCA3 messenger RNA species in benign and malignant prostate tissues'
[patent_app_type] => utility
[patent_app_number] => 09/675650
[patent_app_country] => US
[patent_app_date] => 2000-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 13320
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/368/07368545.pdf
[firstpage_image] =>[orig_patent_app_number] => 09675650
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/675650 | PCA3 messenger RNA species in benign and malignant prostate tissues | Sep 28, 2000 | Issued |
| 09/646541 | Use of dipeptidyl peptidase (DPP4) for suppressing the malignant phenotype of cancer cells | Sep 17, 2000 | Abandoned |
Array
(
[id] => 756622
[patent_doc_number] => 07014848
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-03-21
[patent_title] => 'Enhanced anti-tumor immunity'
[patent_app_type] => utility
[patent_app_number] => 09/663072
[patent_app_country] => US
[patent_app_date] => 2000-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12697
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/014/07014848.pdf
[firstpage_image] =>[orig_patent_app_number] => 09663072
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/663072 | Enhanced anti-tumor immunity | Sep 14, 2000 | Issued |
